StreetAlpha.app
Home › Stocks › LKFT

Lakefront Biotherapeutics NV (LKFT)

Healthcare
$33.31
▼ −0.24%
LAST CLOSE · NOV 20

Lakefront Biotherapeutics is a Belgian biotechnology company developing medicines for serious immune and inflammatory diseases. It last closed at $33.31 on Nov 20, down 0.24% on the day.

AI Auto Pilots
Is LKFT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold LKFT.

Key Stats

Fiscal 2025
Results
Revenue
EUR 1.1B
+303.5% vs a year ago
Net income
EUR 320.9M
+333.1% vs a year ago
Free cash flow
−EUR 271.2M
−24.4% margin
Operating margin
26.5%
EUR 295.0M operating income
Balance sheet
Cash & equivalents
EUR 87.9M
At Dec 31
Shareholder equity
EUR 3.2B
ExchangeNasdaq
Financials history
FY2021: EUR 234.4MEUR 234.4MFY2021FY2022: EUR 241.2MEUR 241.2MFY2022FY2023: EUR 239.7MEUR 239.7MFY2023FY2024: EUR 275.6MEUR 275.6MFY2024FY2025: EUR 1.1BEUR 1.1BFY2025

From LKFT's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 26). Figures are in EUR. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Ratings from the last 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on LKFT
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on LKFT

Technical Analysis

LKFT · as of the Nov 20 close · updated each morning
Uptrend

The stock is 0% above its 20 day and 7% above its 50 day average. It is 10% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 57). The nearest support is the 20 day average at $33.18, and the nearest resistance the Pivot at $33.47.

Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 2.6%/day
Key levels
$36.2452 week high+8.8%
$34.49Swing high (Nov 5)+3.5%
$33.69Pivot R1+1.1%
$33.47Pivot+0.5%
$33.31Last close
$33.1820 day average−0.4%
$33.09Pivot S1−0.7%
$31.0250 day average−6.9%
$29.88200 day average−10.3%
$29.76100 day average−10.7%
$28.71Swing low (Oct 1)−13.8%
$25.6852 week low−22.9%
Indicators
RSI (14)57.02Middle of its rangeNeutral
MACD0.86Below its signal lineBearish
Stochastic46.0Middle of its rangeNeutral
ADX (14)28.6Trending up
Williams %R-62.6Oversold below −80, overbought above −20Neutral
CCI (20)21.2Oversold below −100, overbought above 100Neutral
Rate of change−0.4%Change over 10 sessionsBearish
ATR (14)$0.88Typical daily range, 2.6% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for LKFT

What happened before

See how LKFT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow LKFT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How LKFT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for LKFTHow many large options trades hit LKFT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

LKFT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲57 buying vs 30 selling
  • ▲Shares held by funds +4.8%
  • ▲Funds holding +16
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding9579+20.3%
In funds' top 1045−20.0%
Held by funds–––
New / increased22 / 3511 / 25+58.3%
Reduced / sold out23 / 729 / 21−40.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See LKFT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LKFT is in one of them and how their past LKFT trades turned out.

LKFT in the AI portfolios
Loading…

LKFT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LKFT in an article yet. Here's the latest on the wider market.

LKFT in the news

About Lakefront Biotherapeutics NV

Lakefront Biotherapeutics is a biotechnology company based in Mechelen, Belgium, that develops medicines for patients with serious diseases. Its main focus is immunology, where its lead candidate is an oral medicine being studied in lupus and dermatomyositis, two autoimmune conditions. The company has also decided to wind down its cell therapy work in cancer and is seeking new business development deals to advance its remaining drug candidates.

Headquarters
2800 Mechelen
Founded
1999